Course 2: USP <800> Facilities, Engineering, and Environmental Controls

ACPE Activity Numbers:  0204-0000-18-007-H07-P and 0204-0000-18-007-H07-T
Release Date: September 27, 2018
Expiration Date: September 27, 2021
Activity Type:  Knowledge-based
CE Credits:  0.5
Activity Fee:    $25 member / $30 non-member

This course contains 1 of 4 modules on USP <800>.  If you would like to purchase all 4, please click here for more information.

 

Accreditation for Pharmacists and Pharmacy Technicians

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

This continuing pharmacy education activity is designed for pharmacists and pharmacy-technicians involved in handling hazardous drugs who practice in a wide variety of settings including hospitals, health-systems, and compounding facilities.

Overall Learning Objectives

After participating in this CPE activity, participants should be able to:

  • Name key facilities requirements for the safe receipt, unpacking, storage, and compounding of sterile and nonsterile hazardous drugs
  • Differentiate between primary, secondary, and supplemental engineering controls for containment hazardous drugs during compounding
  • Describe key elements for cleaning and decontamination of areas used for compounding hazardous drugs

Schedule of Educational Activities

CE Information

Title, Description, and Learning Objectives

ACPE #:

0204-0000-18-007-H07-P& T

CE Hours: 0.5

Activity Type: Knowledge-based

Title: Course 2: USP <800> Facilities, Engineering, and Environmental Controls

 

Description: This module will cover key facilities requirements for the safe receipt, unpacking, storage, and compounding of sterile and nonsterile hazardous drugs; primary, secondary, and supplemental engineering controls for containment hazardous drugs during compounding; and key elements for cleaning and decontamination of areas used for compounding hazardous drugs.

 

Learning Objectives:

  • Name key facilities requirements for the safe receipt, unpacking, storage, and compounding of sterile and nonsterile hazardous drugs
  • Differentiate between primary, secondary, and supplemental engineering controls for containment hazardous drugs during compounding
  • Describe key elements for cleaning and decontamination of areas used for compounding hazardous drugs

 

Faculty Information

Ryan A. Forrey, PharmD, MS, FASHP
Senior Manager
Market Development for Hazardous Drug Safety
Becton Dickinson
Franklin Lakes, NJ.

Lindsey B. Amerine, PharmD, MS, BCPS
Associate Director of Pharmacy
University of North Carolina Medical Center
Associate Professor of Clinical Education
UNC Eshelman School of Pharmacy
Durham, NC.

Disclosures

In accordance with the ACPE’s and ACCME’s Standards for Commercial Support, everyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control. 

commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests.

  • Lindsey B. Amerine, PharmD, MS, BCPS - Becton, Dickinson, and Company (BD): speaker
  • Ryan A. Forrey, PharmD, MS, FASHP - Becton, Dickinson, and Company (BD): employee
  • Mark Hamm, PharmD, MBA, BCPS – No relevant financial relationships to disclose
  • Patricia C. Kienle, RPh, MBA, FASHP – USP Compounding Expert Committee: member; The Chapter <800> Answer Book (ASHP): author; Cardinal Health: employee
  • Marc Stranz, PharmD –Visante and Becton, Dickinson, and Company (BD): advisory boards

All other planners, presenters, reviewers, and ASHP staff report no financial relationships relevant to this activity.

Methods and CE Requirements

This activity is one of four interactive course modules, with video presentation, scenarios narrations and assessments posttests. Participants must participate in the entire course, complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP eLearning Portal (http://elearning.ashp.org).  Follow the prompts to claim credit and view your statement of credit within 60 days after completing the activity.

Important Note – ACPE 60 Day Deadline:

Pharmacists/Pharmacy Technicians:  Your credits will be reported directly to CPE Monitor.  To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline.   After the 60 day deadline, ASHP will no longer be able to award credit for this activity.

System Technical Requirements

Courses and learning activities are delivered via your Web browser and Acrobat PDF.  Users should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.